Pyridazinedione-based heterobicyclic covalent linkers and methods and applications thereof
US-2024425465-A1 · Dec 26, 2024 · US
US2016367693A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016367693-A1 |
| Application number | US-201615187169-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 20, 2016 |
| Priority date | Jun 19, 2015 |
| Publication date | Dec 22, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are chemical transformations for the conjugation of unprotected peptide biomolecules. The processes feature several significant advantages over existing methods of peptide modification, including specificity towards selenocysteine over other nucleophiles (e.g., amines, hydroxyls), excellent functional group tolerance, and mild reaction conditions.
Opening claim text (preview).
We claim: 1 . A compound comprising (a) substructure I: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; is a substituted or unsubstituted aryl or heteroaryl radical; x is 0, 1, 2, 3, 4, 5, or 6; and R is H or alkyl; or (b) substructure II: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; is a substituted or unsubstituted aryl or heteroaryl radical, provided is not a perfluoroaryl radical; x is 0, 1, 2, 3, 4, 5, or 6; and R is H or alkyl. 2 . The compound of claim 1 , wherein is a substituted aryl radical. 3 . The compound of claim 1 , wherein is a substituted phenyl radical. 4 . The compound of claim 1 , wherein is an unsubstituted aryl radical. 5 . The compound of claim 1 , wherein is a substituted heteroaryl radical. 6 . The compound of claim 1 , wherein is a substituted indole, pyrazolo, thiophene, pyrimidine, benzofuran, or isoxazole radical. 7 . The compound of claim 1 , wherein is an unsubstituted heteroaryl radical. 8 . The compound of claim 1 , wherein is an unsubstituted indole, pyrazolo, thiophene, pyrimidine, benzofuran, or isoxazole radical. 9 . The compound of claim 1 , wherein or a regioisomer or stereoisomer thereof. 10 . A compound comprising (a) substructure III: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 2 , A 3 , and A 4 are selected from the group consisting of a natural amino acid, an unnatural amino acid, and a plurality of natural amino acids or unnatural amino acids; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; x is 0, 1, 2, 3, 4, 5, or 6; is a substituted or unsubstituted aryl or heteroaryl diradical; and R is H or alkyl; (b) substructure IV: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 2 , A 3 , and A 4 are selected from the group consisting of a natural amino acid, an unnatural amino acid, and a plurality of natural amino acids or unnatural amino acids; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; x is 0, 1, 2, 3, 4, 5, or 6; is a substituted or unsubstituted aryl or heteroaryl diradical, provided is not a perfluoroaryl diradical; and R is H or alkyl; (c) substructure V or substructure VII: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 2 , A 3 , and A 4 are selected from the group consisting of a natural amino acid, an unnatural amino acid, and a plurality of natural amino acids or unnatural amino acids; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; x is 0, 1, 2, 3, 4, 5, or 6; is a substituted or unsubstituted aryl or heteroaryl diradical; and R is H or alkyl; or (d) substructure VI or substructure VIII: wherein, independently for each occurrence, A 1 is H, an amine protecting group, a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; A 2 , A 3 , and A 4 are selected from the group consisting of a natural amino acid, an unnatural amino acid, and a plurality of natural amino acids or unnatural amino acids; A 5 is OH, —O(carboxylate protecting group), a natural or unnatural amino acid, a peptide, an oligopeptide, a polypeptide, or a protein; x is 0, 1, 2, 3, 4, 5, or 6; is a substituted or unsubstituted aryl or heteroaryl diradical, provided is not a perfluoroaryl diradical; and R is H or alkyl. 11 . The compound of claim 10 , wherein is a substituted aryl diradical. 12 . The compound of claim 10 , wherein
by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids · CPC title
the antibody targeting a determinant of a tumour cell · CPC title
Labelling of peptides · CPC title
from mammals · CPC title
by covalent attachment of amino acids or peptide residues · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.